Publications by authors named "Kevin M Budge"

Claim this Profile
I
Immunogenicity Risk Assessment of Biotherapeutics Using an Ex Vivo B Cell Assay.
Kevin M Budge, Ross Blankenship, Patricia Brown-Augsburger, Lukasz K Chlewicki

Antibodies (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rat as a Predictive Model for Human Clearance and Bioavailability of Monoclonal Antibodies.
Jason D Robarge, Kevin M Budge, Lucy Her, Andrea M Patterson, Patricia Brown-Augsburger

Antibodies (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration.
Kevin M Budge, Matthew L Neal, Jason R Richardson, Fayez F Safadi

Mol Neurobiol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration.
Matthew L Neal, Sheila M Fleming, Kevin M Budge, Alexa M Boyle, Chunki Kim

FASEB J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease.
Kevin M Budge, Matthew L Neal, Jason R Richardson, Fayez F Safadi

Mol Neurobiol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.
Matthew L Neal, Alexa M Boyle, Kevin M Budge, Fayez F Safadi, Jason R Richardson

J Neuroinflammation· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis